Answers are grounded in this paper and cite their sources.
A dose conversion ratio of ONA to ABO between 1:2.5 and 1:3.0 provides comparable safety and efficacy for therapeutic movement disorders chemodenervation procedures.
No takes yet. Share an insight, caveat, or question.
Dashtipour et al. (2015) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: